Indonesia Investment Authority

The Indonesia Investment Authority (INA) is Indonesia's sovereign wealth fund, established in 2021 to attract foreign investment and optimize the value of state assets. While it operates across multiple sectors, INA has designated healthcare as a core strategic pillar to improve the country's medical infrastructure and pharmaceutical self-sufficiency. The fund actively invests in healthcare services, pharmaceutical manufacturing, and digital health technologies through partnerships with global investors and local state-owned enterprises. Notable healthcare initiatives include a significant investment in Kimia Farma and collaborations aimed at developing genomic research and biotechnology hubs within Indonesia.